Literature DB >> 20524387

[Drug therapy and hypertension in the newspapers].

Johanne Collin1, David Hughes.   

Abstract

OBJECTIVE: The most recent country-wide Canadian data have revealed that only 33% of people with hypertension take medication and fewer than half of them have their blood pressure under control. One of the most important reasons for difficulty in controlling blood pressure is lack of drug treatment compliance. In addition, media coverage of health facts has an impact on beliefs, attitudes and behaviours related to health. Our goal was to analyze newspaper coverage of drugs related to hypertension.
METHOD: We conducted a thematic content analysis of newspapers covering medications related to hypertension. The study comprised 104 articles drawn from three of the most important francophone daily newspapers in Canada--a reference one, a general broadsheet and a tabloid.
RESULTS: We identified three major themes: 1) drugs as an effective treatment, 2) specific problematic cases, and 3) problems with the pharmacological approach in general. We noted a gradual change from positive to negative as we moved from the most serious newspaper to the most popular. We discuss the Fiske hypothesis which suggests that tabloid-format newspapers are a repository of popular opposition to the discourse of groups who hold power in society.
CONCLUSION: In the tabloid, the most widely-read newspaper in Quebec, medications are often presented in negative fashion in articles on hypertension. However, further studies are required to determine if there is a causal association between media discourse and the phenomenon of lack of drug treatment compliance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524387      PMCID: PMC6973887     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  17 in total

1.  A retrospective study of the accuracy of cancer information in Ontario daily newspapers.

Authors:  Megan M MacDonald; Laurie Hoffman-Goetz
Journal:  Can J Public Health       Date:  2002 Mar-Apr

2.  Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.

Authors:  Alan Cassels; Merrilee A Hughes; Carol Cole; Barbara Mintzes; Joel Lexchin; James P McCormack
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

3.  The portrayal of heart disease in mass print magazines, 1991-2001.

Authors:  Juanne Nancarrow Clarke; Jeannine Binns
Journal:  Health Commun       Date:  2006

4.  Persistence with treatment for hypertension in actual practice.

Authors:  J J Caro; M Salas; J L Speckman; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

5.  Applying the 2005 Canadian Hypertension Education Program recommendations: 3. Lifestyle modifications to prevent and treat hypertension.

Authors:  Rajdeep Padwal; Norman Campbell; Rhian M Touyz
Journal:  CMAJ       Date:  2005-09-27       Impact factor: 8.262

6.  Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study.

Authors:  R Nuesch; K Schroeder; T Dieterle; B Martina; E Battegay
Journal:  BMJ       Date:  2001-07-21

7.  Distribution of blood pressure and hypertension in Canada and the United States.

Authors:  M R Joffres; P Hamet; D R MacLean; G J L'italien; G Fodor
Journal:  Am J Hypertens       Date:  2001-11       Impact factor: 2.689

8.  Reporting research in medical journals and newspapers.

Authors:  V Entwistle
Journal:  BMJ       Date:  1995-04-08

9.  Persistence with treatment in newly treated middle-aged patients with essential hypertension.

Authors:  Sylvie Perreault; Diane Lamarre; Lucie Blais; Alice Dragomir; Djamal Berbiche; Lyne Lalonde; Claudine Laurier; François St-Maurice; Johanne Collin
Journal:  Ann Pharmacother       Date:  2005-08-02       Impact factor: 3.154

10.  Blood pressure demographics: nature or nurture ... ... genes or environment?

Authors:  Joseph Tomson; Gregory Y H Lip
Journal:  BMC Med       Date:  2005-01-07       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.